How CAR T-cell therapies target myeloma at the molecular level
by Anne Grimm, Leipzig University edited by Gaby Clark, reviewed by Robert Egan Editors’ notes Graphical abstract. Credit: Cancer Cell (2025). DOI: 10.1016/j.ccell.2025.10.014 In multiple myeloma, plasma cells proliferate uncontrollably in the bone marrow, disrupting the growth of healthy blood-forming cells. If the disease recurs after treatment or fails to respond, CAR T-cell therapy may be considered. In this innovative […]
How CAR T-cell therapies target myeloma at the molecular level Read More »
